Pursuant to Regulation 29(1) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parmax Pharma has informed that a meeting of the Board of Directors of the Company is proposed to be held on Tuesday, the 29th June, 2021 at 4:00 pm to, consider, approve and take on the record the Audited Financial Results for the quarter and year ended 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.